Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
21.47
+0.16 (0.75%)
Jun 29, 2026, 12:00 PM EDT - Market open
Syndax Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Syndax Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $39. The average 1-year stock price forecast is 81.65% higher than the current stock price, while the lowest is $29 (+35.07%) and the highest is $57 (+165.49%).
Price Target: $39 (+81.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Syndax Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 11 | 11 | 11 | 11 | 11 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $46 | Buy | Maintains | $46 | +114.25% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +86.31% | Jun 15, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $34 → $31 | Buy | Maintains | $34 → $31 | +44.39% | Jun 12, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $34 | Buy | Maintains | $34 | +58.36% | Jun 4, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $29 | Buy | Maintains | $29 | +35.07% | May 21, 2026 |
Financial Forecast
Revenue This Year
344.51M
from 172.35M
Increased by 99.89%
Revenue Next Year
502.75M
from 344.51M
Increased by 45.93%
EPS This Year
-1.70
from -3.29
EPS Next Year
-0.56
from -1.70
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 379.3M | ||
| Avg | 344.5M | ||
| Low | 298.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 120.1% | ||
| Avg | 99.9% | ||
| Low | 73.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.16 | ||
| Avg | -1.70 | ||
| Low | -2.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |